Avalo, a Durham startup using artificial intelligence to help develop climate-resistant crops, has secured $11 million in a Series A investment round.

Sara Imhof, Ph.D., vice president of the focused initiatives team at the North Carolina Biotechnology Center, has been honored by a regional business publication for her inspiring work to lead North ...

Join us for an Ambassador Community Event at UNC Pembroke's Biotech Center on Wednesday, March 19 from 12:00 - 2:00 p.m. Come network with local life sciences professionals, learn about training and ...

Doron Therapeutics, a clinical-stage biotechnology company based in Chapel Hill, has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ...

Redbud has introduced its microfluidics sample prep platform, called Redbud NA1, for use in research and surveillance for ...

This event will bring together industry leaders, solution providers and professionals in the same room to interact in ways that can simplify processes and maximize their efforts to get drugs to ...

“The KickStart Grant Awards help de-risk these technologies by establishing a collaboration agreement between the startup ...

Gov. Roy Cooper announced today that Believer Meats, an Israeli company that is commercializing cultivated meat made from animal cells, plans to build a $123 million, 200,000-square-foot manufacturing ...

Chiesi USA of Cary and its European partner Holostem Terapie Avanzate have received Orphan Drug Designation from the U.S. Food and Drug Administration for an investigational cell-based therapy for a ...

Building an online community is a great way for companies to foster brand loyalty, boost revenue, increase customer engagement, and potentially reduce customer support. However, it's not an easy task.

NCLifeSci is partnering with the Institute for Advanced Learning and Research, NCBiotech and Virginia Bio for AgBio 2025: Innovating Agricultural Resilience. This program will examine agricultural ...

Flourish Research, a multi-site clinical trials company based in Apex, has acquired a California clinical research facility.